InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.735 0.005 (0.68%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$200 Half Yearly Report and Accounts 26 Feb 2016 8:02AM $0.375 $0.735 risen by 96%
$200 Appendix 4C - quarterly 29 Jan 2016 4:29PM $0.515 $0.735 risen by 42.72%
$200 Results of Meeting 27 Jan 2016 7:59PM $0.540 $0.735 risen by 36.11%
$200 Tendon Data Presented at International Hip Conference 21 Jan 2016 9:18AM $0.550 $0.735 risen by 33.64%
$200 Orthocells Cell Factory Granted Patent in US 5 Jan 2016 9:55AM $0.395 $0.735 risen by 86.08%
$200 Notice of General Meeting/Proxy Form 22 Dec 2015 8:05PM $0.370 $0.735 risen by 98.65%
$200 Approval for Human Tendon Study Using Celgro Received 16 Dec 2015 9:44AM $0.355 $0.735 risen by 107.04%
$200 Orthocell Key Scaffold Patent Granted in Canada 9 Dec 2015 9:06AM $0.360 $0.735 risen by 104.17%
$200 Investor Presentation 30 Nov 2015 3:15PM $0.400 $0.735 risen by 83.75%
$200 Results of Meeting 27 Nov 2015 7:03PM $0.470 $0.735 risen by 56.38%
$200 Change in substantial holding SRV 25 Nov 2015 7:07PM $0.455 $0.735 risen by 61.54%
$200 Change in substantial holding MC 25 Nov 2015 7:06PM $0.455 $0.735 risen by 61.54%
$200 Orthocell Key Patents Granted for Celgro and Ortho-ATI 25 Nov 2015 9:32AM $0.460 $0.735 risen by 59.78%
$200 Becoming a substantial holder 23 Nov 2015 2:48PM $0.465 $0.735 risen by 58.06%
$200 Institutional Component of US Led Placement Completed 19 Nov 2015 6:53PM $0.515 $0.735 risen by 42.72%
$200 Appendix 3B 19 Nov 2015 6:34PM $0.515 $0.735 risen by 42.72%
$200 First Singapore Patient Receives Cartilage Therapy Ortho-ACI 18 Nov 2015 9:18AM $0.490 $0.735 risen by 50%
$200 Orthocell to raise up to $4.4 million in US Led Placement 17 Nov 2015 10:35AM $0.535 $0.735 risen by 37.38%
$200 Trading Halt 16 Nov 2015 9:27AM $0.535 $0.735 risen by 37.38%
$200 Positive Initial Results Using Celgro in Dental Study 10 Nov 2015 8:25AM $0.530 $0.735 risen by 38.68%
$200 Appendix 4C - quarterly 30 Oct 2015 6:17PM $0.595 $0.735 risen by 23.53%
$200 Ortho-ATI Tendon Treatment Positive in Workers Comp Study 28 Oct 2015 9:34AM $0.595 $0.735 risen by 23.53%
$200 Appendix 4G 27 Oct 2015 7:44PM $0.595 $0.735 risen by 23.53%
$200 Annual Report to shareholders 27 Oct 2015 7:36PM $0.595 $0.735 risen by 23.53%
$200 Notice of Annual General Meeting/Proxy Form 27 Oct 2015 7:34PM $0.595 $0.735 risen by 23.53%

701 - 725 of 760 results

Page 29 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.